EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives

Diana Elena David, Cringuta Mariana Paraschiv, Laura Elisabeta Checherita, Stefan Andrei Chiriac iD, Gabriela Raluca Grigorasi, Vasile Valeriu Lupu iD, Ancuta Lupu iD, Leonard Iosif Pertea, Gabriela Paduraru, Anca Adam Raileanu, Elena Tataranu, Oana-Raluca Temneanu iD und 3 weitere

Nutrients · 2026

DOI: 10.3390/nu18183091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Diana Elena David und 14 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Gastrointestinal Microbiome. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Programme (PS) 2021-2027.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota is increasingly recognized as an important modulator of cardiovascular health, demonstrating complicated interactions among diet, metabolism, immunology and host physiology. Evidence is accumulating that changes in the composition and function of the gut microbiome may contribute to the pathogenesis of atherosclerosis, hypertension, heart failure, thrombosis and other cardiovascular phenotypes through mechanisms involving microbial metabolites, intestinal barrier dysfunction, inflammation and metabolic dysregulation. In this context, the key question of this narrative review is: how far can modulation of the gut microbiome and its metabolic functions be a clinically meaningful approach in the prevention and treatment of cardiovascular disease, and which of the currently available microbiome-targeted approaches have sufficient mechanistic and clinical evidence to justify translation into cardiovascular practice? To answer this question, we review the evidence linking the gut microbiome to major cardiovascular phenotypes, such as atherosclerosis, hypertension, heart failure, thrombosis and atrial fibrillation, with particular focus on the mechanisms through which microbial metabolites, intestinal barrier dysfunction, inflammation and metabolic dysregulation may affect cardiovascular risk. We then review current and emerging strategies for microbiome modulation, including dietary interventions, prebiotics, probiotics, synbiotics, postbiotics, fecal microbiota transplantation and targeted inhibition of microbial metabolic pathways such as trimethylamine (TMA)/trimethylamine N-oxide (TMAO) production. We also examine bidirectional interactions between cardiovascular drugs and gut microbiome and the role of these interactions in the development of precision methods to cardiovascular prevention and treatment. Finally, we outline the major limitations of the current evidence and highlight goals for future mechanistic, translational and clinical research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesGastrointestinal MicrobiomeHumansProbioticsPrebioticsFecal Microbiota TransplantationAnimalsIntestinal Barrier Function

Stichwörter der Autor:innen

cardiovascular diseasedysbiosisgut microbiomegut–heart axismicrobial metabolitespharmacomicrobiomicsprebioticsprobioticstrimethylamine-N-oxide

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Faculty of Medicine and Biological Sciences, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.

ORCID-Profile: Stefan Andrei Chiriac, Vasile Valeriu Lupu, Ancuta Lupu, Oana-Raluca Temneanu, Tatiana Dramba

Förderung

  • Health Programme (PS) 2021-2027

Zitieren

APA

David, D. E., Paraschiv, C. M., Checherita, L. E., Chiriac, S. A., Grigorasi, G. R., Lupu, V. V., Lupu, A., Pertea, L. I., Paduraru, G., Adam Raileanu, A., Tataranu, E., Temneanu, O. R., Dramba, T., Casapu, A. M., & Esanu, I. M. (2026). Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives. Nutrients. https://doi.org/10.3390/nu18183091

Vancouver

David DE, Paraschiv CM, Checherita LE, Chiriac SA, Grigorasi GR, Lupu VV, et al. Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives. Nutrients. 2026. doi:10.3390/nu18183091

BibTeX
@article{David2026,
  author = {David, Diana Elena and Paraschiv, Cringuta Mariana and Checherita, Laura Elisabeta and Chiriac, Stefan Andrei and Grigorasi, Gabriela Raluca and Lupu, Vasile Valeriu and Lupu, Ancuta and Pertea, Leonard Iosif and Paduraru, Gabriela and Adam Raileanu, Anca and Tataranu, Elena and Temneanu, Oana-Raluca and Dramba, Tatiana and Casapu, Ana-Maria and Esanu, Irina Mihaela},
  title = {Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18183091}
}
Kostenlos starten →